3 | SEC Filings Hub

Filing metadata

Accession number: 0001209191-22-036027
Form type: Form 3
Filer: CRISPR Therapeutics AG
CIK: CIK 1674416
Filed: Jun 10, 2022
Reporting period: Jun 09, 2022
Description: Initial ownership

Documents

0001209191-22-036027-index.htm

Complete submission

0001209191-22-036027.txt

directory listing

Filed by

CRISPR Therapeutics AG